PRO Statistics

Total Valuation

Societe de Promotion Pharmaceutique du Maghreb has a market cap or net worth of MAD 950.00 million. The enterprise value is 1.02 billion.

Market Cap	950.00M
Enterprise Value	1.02B

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Societe de Promotion Pharmaceutique du Maghreb has 1.00 million shares outstanding.

Shares Outstanding	1.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 16.70.

PE Ratio	16.70
Forward PE	n/a
PS Ratio	1.18
PB Ratio	1.96
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.12, with an EV/FCF ratio of -280.90.

EV / Earnings	17.90
EV / Sales	1.26
EV / EBITDA	10.12
EV / EBIT	11.49
EV / FCF	-280.90

Financial Position

The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.27.

Current Ratio	1.74
Quick Ratio	1.00
Debt / Equity	0.27
Debt / EBITDA	1.30
Debt / FCF	-36.18
Interest Coverage	19.11

Financial Efficiency

Return on equity (ROE) is 12.07% and return on invested capital (ROIC) is 9.70%.

Return on Equity (ROE)	12.07%
Return on Assets (ROA)	6.34%
Return on Capital (ROIC)	9.70%
Revenue Per Employee	2.35M
Profits Per Employee	165,883
Employee Count	343
Asset Turnover	0.92
Inventory Turnover	1.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.97% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-10.97%
50-Day Moving Average	1,010.41
200-Day Moving Average	1,011.30
Relative Strength Index (RSI)	40.85
Average Volume (20 Days)	57

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Societe de Promotion Pharmaceutique du Maghreb had revenue of MAD 805.52 million and earned 56.90 million in profits. Earnings per share was 56.90.

Revenue	805.52M
Gross Profit	359.24M
Operating Income	88.65M
Pretax Income	87.79M
Net Income	56.90M
EBITDA	100.66M
EBIT	88.65M
Earnings Per Share (EPS)	56.90

Full Income Statement

Balance Sheet

The company has 62.74 million in cash and 131.18 million in debt, giving a net cash position of -68.44 million or -68.44 per share.

Cash & Cash Equivalents	62.74M
Total Debt	131.18M
Net Cash	-68.44M
Net Cash Per Share	-68.44
Equity (Book Value)	483.87M
Book Value Per Share	483.87
Working Capital	281.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 114.21 million and capital expenditures -117.83 million, giving a free cash flow of -3.63 million.

Operating Cash Flow	114.21M
Capital Expenditures	-117.83M
Free Cash Flow	-3.63M
FCF Per Share	-3.63

Full Cash Flow Statement

Margins

Gross margin is 44.60%, with operating and profit margins of 11.00% and 7.06%.

Gross Margin	44.60%
Operating Margin	11.00%
Pretax Margin	10.90%
Profit Margin	7.06%
EBITDA Margin	12.50%
EBIT Margin	11.00%
FCF Margin	-0.45%

Dividends & Yields

This stock pays an annual dividend of 40.00, which amounts to a dividend yield of 4.21%.

Dividend Per Share	40.00
Dividend Yield	4.21%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	70.30%
Buyback Yield	n/a
Shareholder Yield	4.21%
Earnings Yield	5.99%
FCF Yield	-0.38%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Societe de Promotion Pharmaceutique du Maghreb has an Altman Z-Score of 3.12.

Altman Z-Score	3.12
Piotroski F-Score	n/a